vs
Side-by-side financial comparison of ECB Bancorp, Inc. (ECBK) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($18.3M vs $9.5M, roughly 1.9× ECB Bancorp, Inc.). ECB Bancorp, Inc. runs the higher net margin — 27.3% vs -3.0%, a 30.3% gap on every dollar of revenue. On growth, ECB Bancorp, Inc. posted the faster year-over-year revenue change (33.8% vs -25.6%). ECB Bancorp, Inc. produced more free cash flow last quarter ($9.0M vs $2.2M). Over the past eight quarters, ECB Bancorp, Inc.'s revenue compounded faster (23.8% CAGR vs -10.1%).
ECB Bancorp, Inc. (MD) is a US-based bank holding company. It offers a full suite of retail and commercial banking products including deposit accounts, consumer loans, commercial financing and wealth management solutions, primarily serving individuals and small-to-mid enterprises across local markets in Maryland.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
ECBK vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $18.3M |
| Net Profit | $2.6M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 36.7% | -2.2% |
| Net Margin | 27.3% | -3.0% |
| Revenue YoY | 33.8% | -25.6% |
| Net Profit YoY | 79.5% | 26.7% |
| EPS (diluted) | $0.32 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $18.3M | ||
| Q3 25 | $8.8M | $15.9M | ||
| Q2 25 | $8.0M | $16.1M | ||
| Q1 25 | $6.9M | $18.9M | ||
| Q4 24 | $7.1M | $24.7M | ||
| Q3 24 | $6.6M | $28.3M | ||
| Q2 24 | $6.3M | $25.8M | ||
| Q1 24 | $6.2M | $22.7M |
| Q4 25 | $2.6M | $-554.0K | ||
| Q3 25 | $2.4M | $-1.8M | ||
| Q2 25 | $1.4M | $-1.5M | ||
| Q1 25 | $1.3M | $-1.5M | ||
| Q4 24 | $1.4M | $-756.0K | ||
| Q3 24 | $1.1M | $1.7M | ||
| Q2 24 | $791.0K | $343.0K | ||
| Q1 24 | $621.0K | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 36.7% | -2.2% | ||
| Q3 25 | 37.0% | -9.9% | ||
| Q2 25 | 23.9% | -8.4% | ||
| Q1 25 | 24.9% | -7.2% | ||
| Q4 24 | 27.3% | -2.1% | ||
| Q3 24 | 23.3% | 6.8% | ||
| Q2 24 | 16.9% | 2.0% | ||
| Q1 24 | 13.4% | -5.8% |
| Q4 25 | 27.3% | -3.0% | ||
| Q3 25 | 27.7% | -11.0% | ||
| Q2 25 | 18.0% | -9.3% | ||
| Q1 25 | 18.7% | -8.0% | ||
| Q4 24 | 20.3% | -3.1% | ||
| Q3 24 | 17.2% | 5.9% | ||
| Q2 24 | 12.6% | 1.3% | ||
| Q1 24 | 10.0% | -7.6% |
| Q4 25 | $0.32 | $-0.01 | ||
| Q3 25 | $0.29 | $-0.05 | ||
| Q2 25 | $0.17 | $-0.05 | ||
| Q1 25 | $0.16 | $-0.04 | ||
| Q4 24 | $0.18 | $-0.02 | ||
| Q3 24 | $0.14 | $0.04 | ||
| Q2 24 | $0.09 | $0.01 | ||
| Q1 24 | $0.07 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $82.8M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $171.9M | $37.0M |
| Total Assets | $1.6B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $82.8M | $10.7M | ||
| Q3 25 | $201.9M | $13.6M | ||
| Q2 25 | $191.0M | $12.5M | ||
| Q1 25 | $143.7M | $11.4M | ||
| Q4 24 | $309.4M | $15.7M | ||
| Q3 24 | $114.8M | $12.3M | ||
| Q2 24 | $108.7M | $11.9M | ||
| Q1 24 | $109.8M | $6.6M |
| Q4 25 | $171.9M | $37.0M | ||
| Q3 25 | $169.3M | $37.0M | ||
| Q2 25 | $168.3M | $30.4M | ||
| Q1 25 | $168.6M | $31.5M | ||
| Q4 24 | $168.3M | $32.6M | ||
| Q3 24 | $166.0M | $29.1M | ||
| Q2 24 | $166.5M | $23.5M | ||
| Q1 24 | $165.8M | $20.6M |
| Q4 25 | $1.6B | $57.1M | ||
| Q3 25 | $1.6B | $57.5M | ||
| Q2 25 | $1.5B | $52.6M | ||
| Q1 25 | $1.5B | $54.0M | ||
| Q4 24 | $1.4B | $59.2M | ||
| Q3 24 | $1.4B | $57.1M | ||
| Q2 24 | $1.3B | $53.0M | ||
| Q1 24 | $1.3B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.2M | $2.3M |
| Free Cash FlowOCF − Capex | $9.0M | $2.2M |
| FCF MarginFCF / Revenue | 94.7% | 12.0% |
| Capex IntensityCapex / Revenue | 2.2% | 0.5% |
| Cash ConversionOCF / Net Profit | 3.55× | — |
| TTM Free Cash FlowTrailing 4 quarters | $14.2M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.2M | $2.3M | ||
| Q3 25 | $4.0M | $-1.3M | ||
| Q2 25 | $1.9M | $1.8M | ||
| Q1 25 | $-631.0K | $-3.5M | ||
| Q4 24 | $6.2M | $865.0K | ||
| Q3 24 | $861.0K | $4.3M | ||
| Q2 24 | $1.4M | $1.4M | ||
| Q1 24 | $-429.0K | $-2.4M |
| Q4 25 | $9.0M | $2.2M | ||
| Q3 25 | $4.0M | $-1.5M | ||
| Q2 25 | $1.8M | $1.7M | ||
| Q1 25 | $-649.0K | $-3.5M | ||
| Q4 24 | $6.2M | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | $1.3M | $1.2M | ||
| Q1 24 | $-449.0K | $-2.5M |
| Q4 25 | 94.7% | 12.0% | ||
| Q3 25 | 44.9% | -9.6% | ||
| Q2 25 | 23.0% | 10.5% | ||
| Q1 25 | -9.4% | -18.8% | ||
| Q4 24 | 86.8% | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | 21.4% | 4.5% | ||
| Q1 24 | -7.2% | -11.1% |
| Q4 25 | 2.2% | 0.5% | ||
| Q3 25 | 0.8% | 1.4% | ||
| Q2 25 | 0.6% | 1.0% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 0.8% | 1.6% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.6% | 1.1% | ||
| Q1 24 | 0.3% | 0.6% |
| Q4 25 | 3.55× | — | ||
| Q3 25 | 1.65× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.49× | — | ||
| Q4 24 | 4.31× | — | ||
| Q3 24 | 0.76× | 2.57× | ||
| Q2 24 | 1.75× | 4.20× | ||
| Q1 24 | -0.69× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ECBK
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
